These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31890684)

  • 1. Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial.
    Joharchi K; Memari M; Azargashb E; Saadat N
    J Diabetes Metab Disord; 2019 Dec; 18(2):575-582. PubMed ID: 31890684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.
    Quilici S; Chancellor J; Löthgren M; Simon D; Said G; Le TK; Garcia-Cebrian A; Monz B
    BMC Neurol; 2009 Feb; 9():6. PubMed ID: 19208243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy.
    Devi P; Madhu K; Ganapathy B; Sarma G; John L; Kulkarni C
    Indian J Pharmacol; 2012 Jan; 44(1):51-6. PubMed ID: 22345870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of duloxetine compared with pregabalin and gabapentin in diabetic peripheral neuropathic pain: results from a German observational study.
    Happich M; Schneider E; Boess FG; Wilhelm S; Schacht A; Birklein F; Ziegler D
    Clin J Pain; 2014 Oct; 30(10):875-85. PubMed ID: 24296910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
    Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Julious S; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude EB; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Rice ASC; Bouhassira D; Bennett DL; Selvarajah D;
    Lancet; 2022 Aug; 400(10353):680-690. PubMed ID: 36007534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome.
    Häuser W; Petzke F; Sommer C
    J Pain; 2010 Jun; 11(6):505-21. PubMed ID: 20418173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin.
    Enomoto H; Yasuda H; Nishiyori A; Fujikoshi S; Furukawa M; Ishida M; Takahashi M; Tsuji T; Yoshikawa A; Alev L
    J Pain Res; 2018; 11():1857-1868. PubMed ID: 30271191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies.
    Del Giorno R; Skaper S; Paladini A; Varrassi G; Coaccioli S
    Pain Ther; 2015 Dec; 4(2):169-78. PubMed ID: 26334329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions.
    Wernicke JF; Prakash A; Kajdasz DK; Houston J
    J Diabetes Complications; 2009; 23(5):349-59. PubMed ID: 18768332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial.
    Wernicke JF; Raskin J; Rosen A; Pritchett YL; D'Souza DN; Iyengar S; Knopp K; Le TK
    Curr Ther Res Clin Exp; 2006 Sep; 67(5):283-304. PubMed ID: 24678103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.
    Selvarajah D; Petrie J; White D; Julious S; Bortolami O; Cooper C; Bradburn M; Loban A; Bowler H; Swaby L; Sutherland K; Tesfaye S;
    Trials; 2018 Oct; 19(1):578. PubMed ID: 30348206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.
    Boyle J; Eriksson ME; Gribble L; Gouni R; Johnsen S; Coppini DV; Kerr D
    Diabetes Care; 2012 Dec; 35(12):2451-8. PubMed ID: 22991449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients.
    Wasan AD; Ossanna MJ; Raskin J; Wernicke JF; Robinson MJ; Hall JA; Edwards SE; Lipsius S; Meyers AL; McCarberg BH
    Curr Drug Saf; 2009 Jan; 4(1):22-9. PubMed ID: 19149522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis.
    Alberti FF; Becker MW; Blatt CR; Ziegelmann PK; da Silva Dal Pizzol T; Pilger D
    Clin Rheumatol; 2022 Jul; 41(7):1965-1978. PubMed ID: 35347488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine in the management of diabetic peripheral neuropathic pain.
    Ormseth MJ; Scholz BA; Boomershine CS
    Patient Prefer Adherence; 2011; 5():343-56. PubMed ID: 21845034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of pregabalin in patients with neuropathic cancer pain undergoing morphine therapy.
    Dou Z; Jiang Z; Zhong J
    Asia Pac J Clin Oncol; 2017 Apr; 13(2):e57-e64. PubMed ID: 25530068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative double-blind randomized study on the effectiveness of Duloxetine and Gabapentin on painful diabetic peripheral polyneuropathy.
    Majdinasab N; Kaveyani H; Azizi M
    Drug Des Devel Ther; 2019; 13():1985-1992. PubMed ID: 31354243
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid - Pregabalin Combination for the Treatment of Fibromyalgia Pain.
    Gilron I; Tu D; Holden R; Towheed T; Vandenkerkhof E; Milev R
    JMIR Res Protoc; 2017 Aug; 6(8):e154. PubMed ID: 28778847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective Observational Study Comparing the Efficacy and Safety of Duloxetine and Pregabalin in Diabetic Peripheral Neuropathic Pain.
    Shah I; Ahmad W; Islam M; Jan B; Ul Haq E; Mahmood J; Iqbal N; Shah M
    Cureus; 2022 Sep; 14(9):e28683. PubMed ID: 36199645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
    Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
    Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.